Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soumita Das

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
The Journal of Clinical Investigation|August 15, 2023
Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effectsSirle Saul, Marwah Karim, Luca Ghita, et al.
Nature Communications|June 4, 2021
Drug repurposing screens identify chemical entities for the development of COVID-19 interventionsMalina A Bakowski, Nathan Beutler, Karen C Wolff, et al.
Biorxiv : the Preprint Server for Biology|June 23, 2021
Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effectsSirle Saul, Marwah Karim, Luca Ghita, et al.
Nature Communications|July 10, 2025
PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2Marwah Karim, Manjari Mishra, Chieh-Wen Lo, et al.
Science Translational Medicine|July 3, 2024
PI3Kγ inhibition circumvents inflammation and vascular leak in SARS-CoV-2 and other infectionsRyan M Shepard, Anghesom Ghebremedhin, Isaraphorn Pratumchai, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
The Journal of Clinical Investigation|August 15, 2023
Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effectsSirle Saul, Marwah Karim, Luca Ghita, et al.
Nature Communications|June 4, 2021
Drug repurposing screens identify chemical entities for the development of COVID-19 interventionsMalina A Bakowski, Nathan Beutler, Karen C Wolff, et al.
Biorxiv : the Preprint Server for Biology|June 23, 2021
Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effectsSirle Saul, Marwah Karim, Luca Ghita, et al.
Nature Communications|July 10, 2025
PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2Marwah Karim, Manjari Mishra, Chieh-Wen Lo, et al.
Science Translational Medicine|July 3, 2024
PI3Kγ inhibition circumvents inflammation and vascular leak in SARS-CoV-2 and other infectionsRyan M Shepard, Anghesom Ghebremedhin, Isaraphorn Pratumchai, et al.
Pageof 11